Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Bariatric Surgery as a Potential Risk Factor for Patulous Eustachian Tube: A Comprehensive Literature Review.

Created on 11 Sep 2026

Authors

Karamallah Almasri, Sayed H Almosawi, Amreen Mustafa, Noor Ali, Rabab Kamal

Published in

Cureus. Volume 18. Issue 9. Pages e115965. Epub Sep 08, 2026.

Abstract

Patulous Eustachian tube (PET) is a condition characterized by abnormally persistent patency of the Eustachian tube, resulting in symptoms such as autophony, aural fullness, and otalgia, with weight loss increasingly reported as a potential risk factor. This review aimed to evaluate the association between bariatric surgery and PET. PubMed, Google Scholar, and Scopus were searched from inception to August 2026 for studies addressing PET, bariatric surgery, weight loss, and Eustachian tube dysfunction. Available evidence, predominantly from small observational studies and case reports, demonstrates an association between PET and rapid weight loss following bariatric surgery. Additionally, similar reports following glucagon-like peptide-1 (GLP-1) agonists and severe malnutrition were observed. Bariatric surgery cannot currently be established as an independent cause of PET. Prospective studies using standardized diagnostic criteria, objective Eustachian tube assessment, and serial weight measurements are required to determine whether the rate of weight loss predicts PET development.

PMID:
42724661
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement